medicare coverage for semaglutide all our folks 👋 — this upcoming GLP-1 Bridge Program may help make select weight-loss medications more affordable starting July 2026. 💉✨ Medicare to Cover Blockbuster Obesity

NAION is due to the lack of blood flow to the optic nerve caused by hypertension, hypercholesterolemia, diabetes, cardiovascular and cerebrovascular disease, and obstructive sleep apnea

Try to maintain a consistent sleep schedule for better quality rest

Good oral care is essential

The clinical evidence base for tirzepatide as a GLP-1+GIP agonist is similarly strong, with trial data showing substantial weight reduction in studied populations

This indicates part of the advantage of having GLP1 analogues on board while under caloric deficit, is the suppression of the hunger hormone, something that certainly makes maintaining a reducedcalorie diet easier